Viscosupplementation Market Value to Exceed $2.6 Billion by 2021

Date: 2015-09-16

The viscosupplementation market value will increase from approximately $1.76 billion in 2014 to a little under $2.64 billion by 2021, across the ten major markets (10MM) of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India, with the US continuing to hold the largest share, says research and consulting firm GlobalData.

China has also contributed to the significant increase in APAC viscosupplementation procedure volume over the past decade, and still has a substantial underserved population. The large patient pool, which is finally gaining access to advanced medical treatment as healthcare reform reaches China’s rural regions, will be a key growth driver during the forecast period.

While the 10MM are expected to increase in terms of both procedure numbers and revenues, the market in the five European countries (5EU: France, Germany, Italy, Spain, and the UK) is fairly mature and will experience slow expansion, according to GlobalData.

Surgeons’ dampened enthusiasm about viscosupplementation, along with reimbursement challenges and cost-containment pressures, will continue to negatively impact the 5EU viscosupplementation market expansion, which will be compounded by suppliers focusing on the fast-growing US and APAC regions.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample